Laura Beauregard

DFnet to Exhibit at World Vaccine Congress Washington 2026

DFnet to Exhibit at World Vaccine Congress Washington 2026 DFnet will be exhibiting at World Vaccine Congress Washington 2026, connecting with global leaders across vaccine development and public health. Location: Washington, D.C.Dates: March 30 – April 2, 2026 We will be exhibiting and showcasing DFnet’s unified eClinical platform, designed to support vaccine studies across a range of […]

DFnet to Exhibit at World Vaccine Congress Washington 2026 Read More »

Investing in the Future of Clinical Trials: Welcoming Emily MacKenzie as VP of Software & Technology

Investing in the Future of Clinical Trials: Welcoming Emily MacKenzie as VP of Software & Technology We’re pleased to share that Emily MacKenzie is joining DFnet as Vice President of Software & Technology. As clinical trials evolve, teams are being asked to manage more complexity, more data sources, and higher expectations for quality and oversight.

Investing in the Future of Clinical Trials: Welcoming Emily MacKenzie as VP of Software & Technology Read More »

Lessons Learned from SCOPE Summit 2026: The Industry Is Optimizing for Execution​

Lessons Learned from SCOPE Summit 2026: The Industry Is Optimizing for Execution SCOPE Summit 2026 reinforced something we see every day in real trial delivery. The next phase of transformation in clinical operations will not be defined by bold promises, but by what actually works. Across sessions and conversations, the tone was noticeably more execution

Lessons Learned from SCOPE Summit 2026: The Industry Is Optimizing for Execution​ Read More »

DFnet CEO Amy Apostoleris Recognized Among Top 100 Innovators & Entrepreneurs

DFnet CEO Amy Apostoleris Recognized Among Top 100 Innovators & Entrepreneurs DFnet is proud to congratulate our CEO, Amy Apostoleris, on being named to the Top 100 Innovators & Entrepreneurs list, a global recognition honoring leaders who are driving meaningful innovation and impact across industries. With more than 30 years of experience spanning pharmaceutical, biotech,

DFnet CEO Amy Apostoleris Recognized Among Top 100 Innovators & Entrepreneurs Read More »

DFnet Is Heading to the 17th Annual SCOPE Summit​

DFnet Is Heading to the 17th Annual SCOPE Summit DFnet will be attending the 17th Annual SCOPE Summit in Orlando, connecting with biotech and pharmaceutical sponsors running complex, regulated clinical studies. Location: Orlando, FloridaDates: February 2–5, 2026 DFnet Attendees:Amy Apostoleris, Chief Executive OfficerDaniel Gonzalez, Director of Business Development Meet with DFnet at SCOPE

DFnet Is Heading to the 17th Annual SCOPE Summit​ Read More »

DFdiscover 2025 Release Highlights Webinar: Watch the Recording

DFdiscover 2025 Release Highlights Webinar: Watch the Recording We recently shared the DFdiscover 5.10 and DFengage 2.4 release announcement. If you missed it, you can catch up here. If you weren’t able to join us live, the on-demand recording of our DFdiscover 5.10 and DFengage 2.4 webinar is now available. In this practical session for current

DFdiscover 2025 Release Highlights Webinar: Watch the Recording Read More »

DFdiscover 2025 Is Here. Smarter Workflows. Major ePRO Upgrade.

DFdiscover 2025 Is Here. Smarter Workflows. Major ePRO Upgrade. The latest DFdiscover & DFengage releases are now available. The DFdiscover 5.10 release continues our commitment to providing a strong, flexible clinical data management platform. This version focuses on improvements that enhance usability, reinforce security, and strengthen our ePRO capabilities. This upgrade delivers immediate benefits with

DFdiscover 2025 Is Here. Smarter Workflows. Major ePRO Upgrade. Read More »

Success Story: How the KEN SHE Study Informed WHO’s Global HPV Vaccine Guidance with Support from DFnet

How the KEN SHE Study Informed WHO’s Global HPV Vaccine Guidance with Support from DFnet Transforming Access to Cervical Cancer Prevention In Kenya, cervical cancer remains a leading cause of death among women, claiming more than 2,500 lives each year¹. The disease is largely preventable through vaccination against human papillomavirus (HPV), yet many girls and

Success Story: How the KEN SHE Study Informed WHO’s Global HPV Vaccine Guidance with Support from DFnet Read More »

Success Story: Streamlining Bayley & Vineland Assessments for Angelman Syndrome Trials

Streamlining Bayley & Vineland Assessments for Angelman Syndrome Trials Background Angelman Syndrome is a rare neurogenetic disorder characterized by global developmental delays and behavioral challenges. Clinical outcome assessments such as the Bayley Scales of Infant and Toddler Development and the Vineland Adaptive Behavior Scales are essential for measuring change over time, but their complex scoring

Success Story: Streamlining Bayley & Vineland Assessments for Angelman Syndrome Trials Read More »

Solving Rare Challenges: Q&A Highlights from Our Latest Webinar

Solving Rare Challenges: Q&A Highlights from Our Latest Webinar On June 4, DFnet hosted a webinar on Solving Unique Data Management Challenges in Rare Disease Trials, with over 120 clinical research professionals. If you missed the session or want to revisit it, you can [watch the full recording here]. Below, we’ve shared a few of the

Solving Rare Challenges: Q&A Highlights from Our Latest Webinar Read More »